Hong Kong
# |
Name |
Debt to Equity Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
1.23
|
Dec. 31, 2023 | USD 0.67 | 1.15% |
|
Hong Kong |
|
2 |
0.38
|
Dec. 31, 2023 | USD 0.43 | -0.61% |
|
Hong Kong |
|
3 |
0.32
|
March 31, 2024 | USD 0.16 | -3.92% |
|
Hong Kong |
|
4 |
0.14
|
March 31, 2024 | USD 0.25 | 0.51% |
|
Hong Kong |
|
5 |
0.05
|
Dec. 31, 2023 | USD 0.19 | -0.02% |
|
Hong Kong |
|
6 |
0.04
|
Dec. 31, 2023 | USD 0.15 | -0.02% |
|
Hong Kong |
|
7 |
0.03
|
Dec. 31, 2023 | USD 1.07 | 3.09% |
|
Hong Kong |
|
8 |
0.01
|
March 31, 2024 | USD 0.44 | 1.15% |
|
Hong Kong |
The Drugstores & Retail Pharmacies company in Hong Kong with the highest Debt to Equity Ratio is China Resources Pharmaceutical Group Limited (HKSE: 3320.HK) at 1.23.
The Drugstores & Retail Pharmacies company in Hong Kong with the lowest Debt to Equity Ratio is Alibaba Health Information Technology Limited (HKSE: 0241.HK) at 0.01.
The top 10 Drugstores & Retail Pharmacies companies in Hong Kong by Debt to Equity Ratio are China Resources Pharmaceutical Group Limited, Tycoon Group Holdings Limited, Jacobson Pharma Corporation Limited, JBM (Healthcare) Limited, Jilin Province Huinan Changlong Bio-pharmacy Company Limited, Dawnrays Pharmaceutical (Holdings) Limited, Beijing Tong Ren Tang Chinese Medicine Company Limited and Alibaba Health Information Technology Limited.
The bottom 10 Drugstores & Retail Pharmacies companies in Hong Kong by Debt to Equity Ratio are Alibaba Health Information Technology Limited, Beijing Tong Ren Tang Chinese Medicine Company Limited, Dawnrays Pharmaceutical (Holdings) Limited, Jilin Province Huinan Changlong Bio-pharmacy Company Limited, JBM (Healthcare) Limited, Jacobson Pharma Corporation Limited, Tycoon Group Holdings Limited and China Resources Pharmaceutical Group Limited.